Plain-English translation of NCT06359275 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing a combination treatment for advanced pancreatic cancer using three approaches together: Toripalimab (an immune-boosting drug that helps your body fight cancer), two chemotherapy drugs (paclitaxel and ), and specialized radiation therapy. The goal is to see if using these treatments together can shrink tumors, help people live longer, and improve quality of life.
Pancreatic cancer is very difficult to treat, especially when it cannot be surgically removed or has returned after surgery. Doctors are studying whether combining this medication with chemotherapy and radiation might work better than standard treatments alone.
You likely qualify if…
You likely don't qualify if…
You would receive the medication as an intravenous infusion every three weeks, along with two chemotherapy drugs given on specific days during each 21-day cycle. You would also receive specialized radiation therapy (5 total sessions) delivered during your chemotherapy cycles. The trial lasts at least 18 months total, including at least 18 months of follow-up visits where doctors monitor your progress, check for side effects, and assess whether your cancer is responding to treatment.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China